Published by ChinaMNC · Jingchuan

Pingliang City and Lanzhou University First Hospital Sign Strategic Healthcare Agreement: What It Means for Foreign Founders Setting Up Healthcare Businesses in China

Pingliang City and Lanzhou University First Hospital have signed a strategic healthcare cooperation agreement to build a tight medical consortium, improve specialty alliances, and enhance local medical services. For foreign founders, this signals growing opportunities in China's healthcare sector, but also highlights the need for careful compliance with foreign investment rules. This article explains the practical implications for company registration, licensing, and operations in China.

Key Takeaways for Foreign Founders

• Healthcare sector opening: The agreement focuses on building a tight medical consortium and specialty alliances, indicating continued government investment in healthcare—a sector where foreign investment is possible but subject to specific regulations.
• Entity choice matters: Foreign founders entering China's healthcare market typically use a wholly foreign-owned enterprise (WFOE) or a joint venture (JV) with a Chinese partner; the latter may be required for certain medical activities.
• Licensing is critical: Healthcare services require specific licenses from health commissions; foreign-invested medical institutions face additional approval steps.
• Local partnerships: Collaborations with local hospitals, as seen in this agreement, can provide market access and operational support.
• Compliance focus: Foreign companies must adhere to foreign investment negative list, data security, and medical advertising rules.

What the Agreement Covers

On October 22, Pingliang City and Lanzhou University First Hospital signed a strategic cooperation framework agreement on healthcare. The goal is to establish a long-term, stable, and deeply collaborative medical consortium system, continuously channel high-quality medical resources to lower levels, improve public health, and comprehensively enhance the city's regional medical service capacity.

The agreement includes the signing of a specialty (technical) alliance cooperation agreement between the hospital and the city's health commission. According to the agreement, the two parties will rely on a citywide tight medical consortium to focus on co-building a key discipline system, cultivating medical talent, flexible expert deployment, establishing a telemedicine collaboration network, improving the two-way referral mechanism, enhancing research and innovation capacity, and raising refined operational management levels. They will prioritize eight specialty alliances, including cardiovascular disease, orthopedics, respiratory and critical care medicine, and obstetrics and gynecology, to drive the upgrading of specialty capabilities across all levels of medical institutions in the city.

Implications for Foreign Company Registration

For foreign founders looking to establish a healthcare-related business in China, this agreement underscores the government's focus on improving healthcare infrastructure and services. While the agreement itself involves domestic entities, it reflects a broader trend of healthcare development that may create opportunities for foreign-invested enterprises (FIEs) in areas such as medical technology, telemedicine, health management, and medical training.

However, entering China's healthcare sector requires careful navigation of the regulatory landscape. Below are key considerations for foreign founders.

1. Choosing the Right Entity Structure

Foreign investors can set up a wholly foreign-owned enterprise (WFOE) or a Sino-foreign joint venture (JV) in China. For healthcare services, the Negative List for Foreign Investment Access specifies restrictions. As of the latest version, medical institutions are limited to JVs, and the Chinese party must hold a controlling stake. However, some regions (e.g., pilot free trade zones) may have relaxed rules. For non-medical healthcare businesses (e.g., health tech, consulting), a WFOE is usually feasible.

What this means: If your business involves direct medical services, you may need a Chinese partner. For technology or support services, a WFOE could suffice. Always check the latest negative list and local regulations.

2. Registration Steps and Documents

Registering a company in China typically involves:

• Name pre-approval: Submit proposed names to the local Administration for Market Regulation (AMR).
• Business license: Apply for the business license with the AMR, providing articles of association, investor documents, legal representative information, and registered address proof.
• Post-registration filings: Obtain seals, open a bank account, and complete tax registration.
• Sector-specific approvals: For healthcare, additional licenses from the health commission are required (e.g., Medical Institution Practicing License).

Documents for foreign investors: Notarized and apostilled (or legalized) certificates of incorporation, bank statements, and identification documents of legal representatives. These must be translated into Chinese.

3. Capital Requirements

China has largely abolished minimum registered capital requirements for most companies, but healthcare institutions may have specific capital thresholds set by local health commissions. Foreign investment capital can be contributed in cash or kind; foreign currency must be converted through proper channels. Note: The agreement does not specify capital amounts, so founders should consult local authorities for sector-specific requirements.

4. Licensing and Compliance

Healthcare businesses must comply with:

• Medical Institution License: Required to operate a hospital or clinic.
• Practitioner licenses: Foreign doctors need to obtain Chinese medical practitioner qualifications or work under temporary practice rules.
• Data security: Patient data is sensitive; compliance with the Personal Information Protection Law (PIPL) and Cybersecurity Law is essential.
• Advertising rules: Medical advertising is strictly regulated; pre-approval is often needed.

What this means: Foreign founders should budget time and resources for licensing, and consider partnering with local experts to navigate the process.

5. Tax and Operational Considerations

FIEs in China are subject to corporate income tax (25% standard rate, with preferential rates for high-tech enterprises), value-added tax (VAT), and other taxes. Healthcare services may enjoy VAT exemptions, but eligibility is narrow. Profit repatriation is allowed after tax payments, but document retention is crucial. Local incentives may exist in Pingliang or other cities for healthcare investments; check with local investment promotion agencies.

What this means: Proper tax planning and compliance from day one can save costs and reduce risks.

Why Pingliang?

Pingliang, a city in Gansu Province, is investing in healthcare upgrades. While not a first-tier city, it may offer lower operational costs and local government support for healthcare projects. The agreement with Lanzhou University First Hospital, a major tertiary hospital in Gansu, indicates a commitment to improving medical services. Foreign founders in health tech or medical training could explore partnerships with local institutions.

Next Steps for Foreign Founders

• Assess your business scope: Determine if your activities fall under restricted healthcare services or permitted health tech.
• Choose location: Consider pilot free trade zones with more liberal healthcare policies.
• Engage local advisors: Work with a Chinese law firm or consulting firm to navigate registration and licensing.
• Prepare documents: Ensure all foreign documents are properly notarized and translated.
• Connect with local partners: Attend industry events or reach out to health commissions to understand local needs.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.

Call to Action: For assistance with registering and operating a company in China, foreign founders can contact ChinaMNC on WhatsApp / WeChat at +86 153 1898 8535.